Baidu
map

SCI TRANSL MED:个性化康复算法帮助中风患者恢复运动能力

2017-07-23 海北 MedSci原创

神经性疾病后,患者往往需要进行步行功能恢复,而步行功能的恢复会涉及患者身体机能和重力之间的相互作用。尽管人们已经知道重力依赖的步行能力以及积极参与促进这种学习的重要性,但是至今为止,步行能力恢复过程中的基本组成部分受到的关注还比较少。

神经性疾病后,患者往往需要进行步行功能恢复,而步行功能的恢复会涉及患者身体机能和重力之间的相互作用。尽管人们已经知道重力依赖的步行能力以及积极参与促进这种学习的重要性,但是至今为止,步行能力恢复过程中的基本组成部分受到的关注还比较少。

为了解决这些问题,来自瑞士联邦理工学院的科学家们开发了一种基于患者特异性运动障碍,能够将作用于躯干的多向力个性化的自适应算法。研究人员发现,在大型安全环境中,高度参与性运动期间,将该算法运用于人机界面能够重新建立步态动力学。

在患有脊髓损伤或是脑卒中的患者中间,使用这种多向重力辅助措施能够建立自然的行走。在受损较轻的患者中,该辅助措施还能够帮助患者增强技巧性运动控制。经过一小束的多向重力辅助训练,患者能够立刻提高不依赖机械辅助的运动能力。相反,在跑步机上行走相同的距离并不会改善步行能力。

因此,研究人员的研究成果表明,精确的躯干支持对于步行能力恢复的重要性,并展示了潜在的临床运用前景。


原始出处:

Jean-Baptiste Mignardot et al. A multidirectional gravity-assist algorithm that enhances locomotor control in patients with stroke or spinal cord injuryScience Translational Medicine, 2017; 9 (399): eaah3621 DOI: 10.1126/scitranslmed.aah3621


本文系梅斯医学(MedSci)原创编译整理,转载需授权




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2067256, encodeId=c142206e2562b, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Mar 25 10:17:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656833, encodeId=36c2165683379, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Apr 29 07:17:00 CST 2018, time=2018-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499986, encodeId=94af1499986f2, content=<a href='/topic/show?id=a40c9421969' target=_blank style='color:#2F92EE;'>#运动能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94219, encryptionId=a40c9421969, topicName=运动能力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=058e9400974, createdName=xzw116, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538065, encodeId=7eb215380651c, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607864, encodeId=1b91160e86415, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225465, encodeId=c7da22546554, content=值得学习分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrs2asVmGicNahCpBSxNUbSuA4vpeiazhWPdV79iaSIJsvMiaGECEouckrnOYc6073M9RbpNPL6qU9SdfB5BsicIqON4X/0, createdBy=f47f2017208, createdName=1e20390em99(暂无匿称), createdTime=Sun Jul 23 15:24:53 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2067256, encodeId=c142206e2562b, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Mar 25 10:17:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656833, encodeId=36c2165683379, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Apr 29 07:17:00 CST 2018, time=2018-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499986, encodeId=94af1499986f2, content=<a href='/topic/show?id=a40c9421969' target=_blank style='color:#2F92EE;'>#运动能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94219, encryptionId=a40c9421969, topicName=运动能力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=058e9400974, createdName=xzw116, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538065, encodeId=7eb215380651c, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607864, encodeId=1b91160e86415, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225465, encodeId=c7da22546554, content=值得学习分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrs2asVmGicNahCpBSxNUbSuA4vpeiazhWPdV79iaSIJsvMiaGECEouckrnOYc6073M9RbpNPL6qU9SdfB5BsicIqON4X/0, createdBy=f47f2017208, createdName=1e20390em99(暂无匿称), createdTime=Sun Jul 23 15:24:53 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
    2018-04-29 bsmagic9140
  3. [GetPortalCommentsPageByObjectIdResponse(id=2067256, encodeId=c142206e2562b, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Mar 25 10:17:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656833, encodeId=36c2165683379, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Apr 29 07:17:00 CST 2018, time=2018-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499986, encodeId=94af1499986f2, content=<a href='/topic/show?id=a40c9421969' target=_blank style='color:#2F92EE;'>#运动能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94219, encryptionId=a40c9421969, topicName=运动能力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=058e9400974, createdName=xzw116, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538065, encodeId=7eb215380651c, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607864, encodeId=1b91160e86415, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225465, encodeId=c7da22546554, content=值得学习分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrs2asVmGicNahCpBSxNUbSuA4vpeiazhWPdV79iaSIJsvMiaGECEouckrnOYc6073M9RbpNPL6qU9SdfB5BsicIqON4X/0, createdBy=f47f2017208, createdName=1e20390em99(暂无匿称), createdTime=Sun Jul 23 15:24:53 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2067256, encodeId=c142206e2562b, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Mar 25 10:17:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656833, encodeId=36c2165683379, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Apr 29 07:17:00 CST 2018, time=2018-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499986, encodeId=94af1499986f2, content=<a href='/topic/show?id=a40c9421969' target=_blank style='color:#2F92EE;'>#运动能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94219, encryptionId=a40c9421969, topicName=运动能力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=058e9400974, createdName=xzw116, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538065, encodeId=7eb215380651c, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607864, encodeId=1b91160e86415, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225465, encodeId=c7da22546554, content=值得学习分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrs2asVmGicNahCpBSxNUbSuA4vpeiazhWPdV79iaSIJsvMiaGECEouckrnOYc6073M9RbpNPL6qU9SdfB5BsicIqON4X/0, createdBy=f47f2017208, createdName=1e20390em99(暂无匿称), createdTime=Sun Jul 23 15:24:53 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2067256, encodeId=c142206e2562b, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Mar 25 10:17:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656833, encodeId=36c2165683379, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Apr 29 07:17:00 CST 2018, time=2018-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499986, encodeId=94af1499986f2, content=<a href='/topic/show?id=a40c9421969' target=_blank style='color:#2F92EE;'>#运动能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94219, encryptionId=a40c9421969, topicName=运动能力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=058e9400974, createdName=xzw116, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538065, encodeId=7eb215380651c, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607864, encodeId=1b91160e86415, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225465, encodeId=c7da22546554, content=值得学习分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrs2asVmGicNahCpBSxNUbSuA4vpeiazhWPdV79iaSIJsvMiaGECEouckrnOYc6073M9RbpNPL6qU9SdfB5BsicIqON4X/0, createdBy=f47f2017208, createdName=1e20390em99(暂无匿称), createdTime=Sun Jul 23 15:24:53 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2067256, encodeId=c142206e2562b, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Mar 25 10:17:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656833, encodeId=36c2165683379, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Apr 29 07:17:00 CST 2018, time=2018-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499986, encodeId=94af1499986f2, content=<a href='/topic/show?id=a40c9421969' target=_blank style='color:#2F92EE;'>#运动能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94219, encryptionId=a40c9421969, topicName=运动能力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=058e9400974, createdName=xzw116, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538065, encodeId=7eb215380651c, content=<a href='/topic/show?id=e835226210e' target=_blank style='color:#2F92EE;'>#中风患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22621, encryptionId=e835226210e, topicName=中风患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b5612933772, createdName=sunylz, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607864, encodeId=1b91160e86415, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 25 06:17:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225465, encodeId=c7da22546554, content=值得学习分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrs2asVmGicNahCpBSxNUbSuA4vpeiazhWPdV79iaSIJsvMiaGECEouckrnOYc6073M9RbpNPL6qU9SdfB5BsicIqON4X/0, createdBy=f47f2017208, createdName=1e20390em99(暂无匿称), createdTime=Sun Jul 23 15:24:53 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
    2017-07-23 1e20390em99(暂无匿称)

    值得学习分享

    0

相关资讯

Ann Neurol: CT灌注成像用于风患者血管内治疗预后评估

对于中风后18小时内进行血管内治疗的患者, CT灌注成像结果对预测患者预后表现出极高的准确性,是用于患者预后评价的潜在方法

Circulation:替卡格雷和阿司匹林在卒中患者中抗凝效果的比较性研究

患有轻度急性缺血性卒中(AIS)或短暂性脑缺血发作(TIA)的患者处于中风的高风险,需要接受有效的抗血小板治疗。 然而,过度的抗血小板治疗会伴随着大出血的风险。 SOCRATES试验是首次用替卡格雷在AIS或TIA患者中进行试验,并将替卡格雷的疗效和安全性与阿司匹林进行了比较。 该研究存在一个独立的审判委员会,双盲,并且根据PLATO、TIMI和GUSTO的定义将出血进行分类。 颅内出血(

中国版中风识别法发布:1-2-0三步识别,快速就医

日前,中国卒中学会中风120特别行动组制作的公益短视频——《中风1-2-0:飞越中风陷阱,抢救争分夺秒》,在北京向全球发布,该视频教您2分钟内学会如何识别中风,避免3个中风陷阱,从而减少致命延迟,抢救更多生命。据中风120创始人、中国卒中学会中风120特别行动组组长、复旦大学附属闵行医院赵静教授说,中风又称“卒中”,我国每年大约有200万中风患者死亡,且呈现年轻化趋势。我国中风发病率、致残率和死亡

家长为了考试让孩子吃兴奋剂!兴奋剂增加中风概率

中考体育测试本是为让学生加强锻炼,提高身体素质。然而,记者调查发现,一些学生为拿高分,竟服食含有兴奋剂类药物。这不仅背离考试初衷,更会危害学生健康。南京体育学院运动健康科学系主任、运动生理学教授孙飙教授认为,这种为了达到一时目的,铤而走险的方法非常不可取。采用“兴奋剂”提高成绩,本身就是作弊行为,会受到相应的处罚。另外孩子身体尚未完全发育成熟,会对身体造成很大的伤害,甚至可能会出现不可预知的意外。

Diabetic Med:不同血压水平的Ⅱ型糖尿病患者的中风风险

近日,国际杂志 《Diabetic medicine》上在线发表一项关于基于人群的病例对照研究,以研究比较与瑞典一般人群相比,具有不同血压水平的Ⅱ型糖尿病患者的中风风险。

辟谣|流口水是中风先兆,这说法有没有理

网络上流传“流口水是中风先兆”的说法,认为长年不明原因流口水,如果没有牙痛、口腔炎症等原因,首先要考虑是否为中风前兆。不少患者惊恐万分,纷纷就诊,甚至不惜做头颅核磁共振MRI检查。那么,“流口水是中风先兆”是真的吗?上海中医药大学附属曙光医院传统中医科副主任医师吴欢认为,首先,流口水的人群涉及面广,常见的有婴幼儿流口水,有老年人,也有部分中年人。其次,流口水的形式也很多,有睡觉打瞌睡位置低的一侧口

Baidu
map
Baidu
map
Baidu
map